When to use
Brain MRI is the most sensitive method for acute ischemia (DWI), demyelinating lesions (multiple sclerosis), epilepsy, dementia, tumors, CNS infections and vascular malformations. In emergencies, CT remains first-line due to speed; MRI completes the workup.
What to evaluate
- Diffusion (DWI/ADC): acute restrictions and vascular distribution pattern.
- FLAIR: white matter lesions, MS distribution pattern (McDonald criteria).
- Post-gadolinium T1: focal enhancement, pattern (ring, solid, leptomeningeal).
- Susceptibility-weighted (SWI/SWAN): microhemorrhages, deposits.
- Deep structures, posterior fossa, sella, skull base.
Interactive template
Fill the blanks0/0
Técnica:
Exame realizado com aquisições multiplanares pelas técnicas de spin-echo pesada em T1 antes e após a administração endovenosa de contraste paramagnético (incluindo injeção dinâmica) e de fast spin-echo pesada em T2.
Análise:
- Cavidade selar: forma e dimensões normais.
- Adeno-hipófise: dimensões conservadas e características de sinal normais.
- Neuro-hipófise: tópica.
- Haste hipofisária: centrada e de calibre preservado
- Cisterna suprasselar: livre.
- Quiasma óptico: sem compressão.
- Seios cavernosos: livres.
Comparação: Estudos anteriores não disponíveis para a análise.
Conclusão:
Exame de ressonância magnética da hipófise dentro dos padrões da normalidade.
How to use
- Replace each [...] with the exam's measurement or descriptor.
- Adapt the conclusion to your service protocol before signing.
- Use the template as a starting point — not a replacement for physician review.
- In Laudos.AI, dictate findings in natural speech and the AI structures text in this format for review.
Frequently asked
- Isolated DWI restriction in acute ischemia — useful window?
- Diffusion restriction appears in minutes to hours and persists for days to weeks. ADC pseudonormalizes around 7–10 days — always correlate with FLAIR (DWI/FLAIR mismatch can estimate window).
- Multiple sclerosis — current criteria?
- McDonald 2017 criteria: dissemination in space (lesions in ≥ 2 of 4 typical regions) and time (enhancing + non-enhancing lesions simultaneously, or new lesion on follow-up MRI).
- When to order perfusion / spectroscopy?
- For brain tumor characterization (glioma grading), differentiation of recurrence vs radionecrosis and suspected metabolic disease.
References
- Thompson AJ et al., Lancet Neurol 2018 (McDonald 2017).
- Powers WJ et al., Stroke 2019.